In mammalian brains, D-serine has been shown to be required for the regulation of glutamate neurotransmission as an endogenous co-agonist for the N-methyl-D-aspartate type glutamate receptor that is essential for the expression of higher-order brain functions. The exact control mechanisms for the extracellular D-serine dynamics, however, await further elucidation. To obtain an insight into this issue, we have characterized the effects of agents acting at the a-amino-3-hydroxy-5-methyl-4-isoxazolepropioinic acid (AMPA) type glutamate receptor on the extracellular D-serine contents in the medial prefrontal cortex of freely moving rats by an in vivo microdialysis technique in combination with high-performance liquid chromatography with fluorometric detection. In vivo experiments are needed in terms of a crucial role of D-serine in the neuron-glia communications despite the previous in vitro studies on AMPA receptor-D-serine interactions using the separated preparations of neurons or glial cells. Here, we show that the intra-cortical infusion of (S)-AMPA, an active enantiomer at the AMPA receptor, causes a significant and concentration-dependent reduction in the prefrontal extracellular contents of D-serine, which is reversed by an AMPA/kainate receptor antagonist, 2,3-dioxo-6-nitro-1,2,3,4tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt, and a calcium permeable AMPA receptor antagonist, 1-naphthyl acetyl spermine. The D-serine reducing effects of (S)-AMPA are augmented by co-infusion of cyclothiazide that prevents AMPA receptor desensitization. Our data support the view that a calcium permeable AMPA receptor subtype may exert a phasic inhibitory control on the extracellular D-serine release in the mammalian prefrontal cortex in vivo.
Introduction
It is widely accepted that, in mammalian brains, D-serine is an endogenous co-agonist for the N-methyl-D-aspartate (NMDA) type glutamate receptor that is essential for the control of a variety of higher-order brain functions and neuronal cell viability. This concept is based on essential observations that D-serine exhibits a brain-predominant and NMDA receptor-like distribution and selective binding to the glycine modulatory site of the glutamate receptor and that a specific elimination of D-serine from brain tissues results in reduced NMDA receptor activity (for a review, see Nishikawa, 2011) . These features of D-serine suggest the presence of a fine regulatory system that maintains an appropriate extracellular D-serine signal in the brain. Indeed, substantial extracellular contents of D-serine have also been demonstrated to be highly correlated with the densities of the NMDA receptors in rat brains (Hashimoto et al., 1995) and to be altered by manipulation of the neural and glial cell activities in the prefrontal cortical region of freely moving rats (Hashimoto et al., 1995 ; Kanematsu et al., 2006) , in brain slices or cell cultures (Rosenberg et al., 2010 ; Sullivan and Miller, 2010) . However, the exact molecular and cellular mechanisms underlying the regulation of the extracellular D-serine contents still remain unclear.
Several lines of evidence have indicated that glutamate neurotransmission modifies the extracellular D-serine contents. Thus, in vitro studies using astrocytes, neurons in the primary culture, C6 glioma cells and intact retina have shown that the extracellular release of D-serine is increased by glutamate, a-amino-3-hydroxy-5-methyl-4isoxazolepropioinic acid (AMPA) and kainic acid (for a review, see Nishikawa, 2011) . In contrast, NMDA and kainic acid were reported to reduce the D-serine contents in the striatal extracellular fluid collected by in vivo dialysis experiments (Hashimoto et al., 2000) . These discrepancies could at least partly be due to the differences in the interactions among the cells and molecules between the in vitro and in vivo preparations. In terms of the involvement of D-serine in the communications between neuronal and glial cells (Nishikawa, 2011) , not only in vitro but also in vivo experiments are needed to analyse the control of brain extracellular D-serine concentrations. However, there is so far no in vivo evidence for the possible AMPA receptor-D-serine interactions in the brain.
In the present study, to gain a deeper insight into the glutamatergic control of extracellular D-serine signalling, we have characterized the effects of agents acting at the AMPA receptor on the extracellular D-serine contents in the rat medial prefrontal cortex (mPFC) using an in vivo dialysis technique. We also measured the extracellular levels of taurine that have been reported to be under an excitatory influence by the AMPA receptor in vivo and of some D-serine-related amino acids including L-glutamate, L-glutamine, glycine and L-serine.
Materials and method

Animals and reagents
The present animal experiments were performed in strict accordance with the guidance of the Tokyo Medical and Dental University and were approved by the Animal Investigation Committee of the Institution. Male Wistar rats (ST strain ; Clea Japan, Inc., Japan) at post-natal day 56, weighing 200-250 g, were used. The animals were housed at 23.0¡0.5 xC in a humidity-controlled room under a 12-h light/dark cycle (lights on 08 : 00 hours) and had free access to food and water.
Chemicals
(S)-AMPA, cyclothiazide (CTZ), 2,3-dioxo-6-nitro-1,2,3,4tetrahydrobenzo[f]-quinoxaline-7-sulfonamide disodium salt (NBQX) and 1-naphthyl acetyl spermine trihydrochloride (NASPM) were purchased from Tocris Bioscience (USA). Recombinant human D-amino acid oxidase (hDAAO) was prepared according to the method of Kawazoe et al. (2006) . All other chemicals were of ultrapure grade and commercially available. An ampoule solution of pentobarbital was diluted with physiological saline for the intraperitoneal injection of the animals. The doses always refer to the free bases.
In vivo microdialysis
The in vivo microdialysis was performed as previously reported with some modifications (Hashimoto et al., 1995 ; Nishijima et al., 1996 ; Kanematsu et al., 2006) . The rats were anaesthetized with pentobarbital (40 mg/kg i.p.) and mounted on a stereotaxic frame. A straight-shaped cellulose dialysis tube (3.0 mm in length, 0.16 mm internal diameter, molecular weight cut-off 50 000 ; EICOM Co., Ltd., Japan) was then implanted into the mPFC (A+2.2 mm, V+5.0 mm, L x0.7 mm) according to the atlas of Paxinos and Watson (2005) . Two days after surgery, the dialysis probe was perfused with a Ringer solution (147 mM NaCl ; 4 mM KCl ; 1.3 mM CaCl 2 ; pH 7.4) at the flow rate of 2 ml/min in a freely moving rat. After stabilizing for at least 80 min, the dialysate samples were collected every 20 min. The first three samples were used to determine the basal release of each amino acid and then the various experiments were started by the fourth sampling of the dialysate as time 0. A 20-min application of (S)-AMPA was performed by perfusing the Ringer solution, including different concentrations of (S)-AMPA from time 20 to 40 min. In some experiments, the Ringer solution with NBQX (100 mM), NASPM (300 mM) or CTZ (100 mM) was continuously infused from time 0. Our previous studies, in accordance with the data reported by other research groups (Korf and Venema, 1985 ; Westerink and Tuinte, 1986 ; Paulsen et al., 1987) , confirmed that the above experimental conditions allowed us to observe : (1) a terodotoxin-reversible depolarizationinduced increase in the extracellular release of classical amino acid transmitters, glutamate and glycine (Hashimoto et al., 1995) ; (2) a marked reduction or complete elimination of the extracellular release of a classical transmitter, dopamine, by cessation of the nerve impulse flow or calcium chelation (Nishijima et al., 1996) ; (3) changes in the glial cell activity by monitoring the extracellular glutamine (Kanematsu et al., 2006) .
High-performance liquid chromatography (HPLC) with fluorometric detection
The collected dialysates were stored at x80 xC until derivatization following the addition of D-homocysteic acid as the internal standard. For quantification of the amino acids by HPLC with fluorometric detection, an aliquot of each sample was derivatized with N-tert-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde for 2 min at room temperature. The derivatized sample was immediately applied to the HPLC system and then analysed on a 4-mM (particle size) Nova-Pak C18 column (300 mmr 3.9 mm) (Waters Co., Ltd., Japan). The column was operated at the constant flow rate of 0.8 ml/min at 35 xC. Mobile phase A was 0.1 M acetate buffer (pH 6.0) containing 12 % acetonitrile and mobile phase B was the acetate buffer containing 20 % acetonitrile. The separation of the amino acid derivatives was performed using a linear gradient from mobile phase A to B in 53 min. The fluorescent amino acid derivatives were detected using a Waters 2475 Multi l fluorescence detector spectrofluorometer (Waters Co., Ltd.). The excitation and emission wavelengths were 344 and 443 nm, respectively. The cortical dialysate levels of the L-and non-chiral amino acids determined in the present study are in good agreement with those previously reported (Hashimoto et al., 1995 ; Kanematsu et al., 2006) .
We have proven the presence of endogenous D-serine by gas chromatography (GC) and GC with mass spectrometry (GC-MS) and demonstrated excellent agreement in the quantitative measurements among our GC, GC-MS and HPLC assay methods (for a review, see Nishikawa, 2011) . Because the D-serine peak in the HPLC method was not inspected mass spectrometrically, we presently confirmed the precision of the D-serine identification in the dialysates by observing that the D-serine peak was specifically and completely removed after treating the supernatants with a D-serine degrading enzyme hDAAO ( Fig. 1 c, d ), but not a boiled hDAAO ( Fig. 1 e, f) or vehicle ( Fig. 1 a, b ).
Data analysis
The average concentration of each substance during the period preceding the drug treatment (three measurements were performed every 20 min) was used as the baseline control value (=100 %). The individual data are expressed as percentages of this baseline period. The means with S.E.M. of the results obtained from 4-7 animals were calculated using the corresponding periods. The areas under the curves (AUC) of the concentration vs. time plots for the dialysate amino acids at 40-180 min of infusion from time 0 (see above in ' In vivo microdialysis ') were calculated and used as the overall measures of the treatment effects (Matthews et al., 1990) .
For comparison between the two groups, the statistical evaluations were performed using the unpaired twotailed Student's t test (the homogeneous variance for each experimental group) or Aspin-Welch's t test (the heterogeneous variance for each experimental group). Statistical differences among more than three groups were estimated by Bonferroni's method. We evaluated using Barlett's test the homogeneity of the variance of the data sets for statistical analyses. In the dose-finding experiments, we used Dunnet's test for statistical comparison among more than three groups.
Results
Effects of AMPA receptor agents on the extracellular contents of D-serine in the rat mPFC
The concentration ranges from 10 to 500 mM of the intracortically infused (S)-AMPA via the dialysis probe were chosen based upon the following reasons : (1) the (S)-AMPA concentrations outside the dialysis probe is estimated as the 10 x6 -10 x5 M ranges in case of application of the aforementioned original concentrations because we determined the efficiency of dialysis across the membrane as approximately 10 % (mean with S.E.M. :
10.42¡0.17, n=4) for (S)-AMPA (data not shown) ; (2) the 10 x4 M concentrations of L-glutamate, which has been reported to be approximately one-fifth to 10 times potent In these verification experiments, the standard mixture of amino acids or the prefrontal dialysates were incubated at 37 xC for 1 h in a total volume of 80 ml in the presence of hDAAO at 50 mg/ml, boiled hDAAO or its vehicle and flavin adenine dinucleotide at 100 mM. The reaction was terminated by adding trichloroacetic acid (at a final content of 4 %) and the resulting mixture was centrifuged at 14 500 g for 20 min at 4 xC after the addition of the internal standard, D-homocysteic acid. and the open symbols display the period of (S)-AMPA (100 mM) infusion through the dialysis probe into the cortical portion. The concentrations of D-serine in the cortical dialysates collected every 20 min were quantitatively determined using high-performance liquid chromatography with fluorometric detection. Each point represents the mean with S.E. mean of data obtained from 4-7 animals and expressed as a percentage of the respective basal D-serine as AMPA for the AMPA receptor subunits including Glu A1 , Glu A2 and Glu A3 (Traynelis et al., 2010) , are considered to occur after depolarization, as depolarization by veratrine or veratrine causes a marked increase in the extracellular L-glutamate contents that is maximally about 10 times higher than the basal levels of around 35 mM in this study ; (3) these concentrations do not seem to be cytotoxic because the 10 x5 -10 x4 M ranges of (S)-AMPA or AMPA have been used for bath application in the in vitro experiments using the cell culture or slice preparation.
As shown in Fig. 2a , the 20-min intra-mPFC perfusion of (S)-AMPA (10-500 mM) via the microdialysis tubing caused a concentration-related decrease in the extracellular contents of D-serine in the cortical portion as compared to the Ringer solution-perfused controls (Fig. 2 a, b) in the rat. The local infusion of (S)-AMPA at 100 and 500 mM elicited a significant reduction in the extracellular levels of D-serine from 40 to 140 min postinfusion (80 to 180 min from time 0) while that at 30 mM diminished significantly the dialysate D-serine contents only at time 80 min (Fig. 2 a) . There was no significant change at any time following the intracortical application of 10 mM (S)-AMPA (Fig. 2 a) . The decreased responses as evaluated by AUC were statistically significant after perfusion of 100 and 500 mM, but not at 10 and 30 mM (S)-AMPA (Fig. 2b) .
We also investigated the relationship of a rapid desensitization process following the stimulation of the AMPA receptor (Trussell et al., 1988 ; Sun et al., 2002) with the D-serine decreasing effects of (S)-AMPA using an allosteric potentiator of the AMPA receptor, CTZ, that slows its desensitization (Partin et al., 1993 ; Yamada and Tang, 1993 ; Fucile et al., 2006 ; Krintel et al., 2012) . CTZ (100 mM) significantly enhanced the ability of 100 mM (S)-AMPA to reduce the extracellular D-serine contents without its own influence on the D-amino acid contents ( Fig. 2 c, d) when assessed both by the data at each timepoint (from time 80 to 140 min and at time 180 min) and by AUC. These results suggest that the decreased responses of the extracellular D-serine concentrations to the prolonged (20 min) perfusion of (S)-AMPA are not due to the desensitization of the AMPA receptor, but produced by its stimulation. In the dialysates collected from 20 to 40 min following the start of the local perfusion of (S)-AMPA with CTZ, but not of (S)-AMPA at 10 to 500 mM alone, there was a small but significant increase in the D-serine contents (Fig. 2 a, c) .
The D-seine decreasing effects of (S)-AMPA at 100 mM were completely eliminated by its co-infusion with a competitive AMPA receptor-preferring antagonist, NBQX, 100 mM (Fig. 2 e, f) or a selective calcium permeable AMPA receptor antagonist, NASPM, at 300 mM (Fig. 2 g, h) when estimated both by the data at each time-point (from time 80 to 140 min for NBQX and at time 100 min for NASPM) and by AUC, while NBQX or NASPM alone failed to alter the cortical extracellular D-serine concentrations (Fig. 2 e-h) .
Effects of AMPA receptor agents on the extracellular contents of taurine in the rat mPFC
In contrast to D-serine, there was a concentrationdependent increase in the extracellular taurine contents in the rat mPFC by the local infusion of (S)-AMPA (10-500 mM) into the cortical area ( Fig. 3 a, b) . The local infusion of (S)-AMPA at 100 and 500 mM elicited a significant elevation in the extracellular levels of taurine from 20 to 140 min post-infusion (60 to 180 min from time 0) whereas that at 30 mM augmented significantly the dialysate taurine contents only at time 60 min (Fig. 3 a) . There was no significant change in those at any time following the intracortical application of 10 mM (S)-AMPA (Fig. 3a) . The augmented responses as evaluated by AUC were statistically significant after infusion of 100 and 500 mM, but not at 10 and 30 mM, (S)-AMPA ( Fig. 3 b) .
The taurine increasing effects of (S)-AMPA at 100 mM were significantly enhanced and completely abolished in the presence of CTZ ( Fig. 3 c, d) at 100 mM and of NBQX at 100 mM ( Fig. 3 e, f) , respectively, when estimated both by the data at each time-point and by AUC, whereas neither CTZ ( Fig. 3 c, d) nor NBQX ( Fig. 3 e, f) changed the basal extracellular contents of taurine. In contrast, NAPSM at 300 mM did not modulate the basal contents and the ability of (S)-AMPA at 100 mM to elevate the prefrontal extracellular taurine levels ( Fig. 3 g, h) .
Effects of AMPA receptor agents on the extracellular contents of L-serine, glycine, L-glutamate and L-glutamine in the rat mPFC
The prefrontal extracellular contents of L-serine, which is converted to D-serine by serine racemase (Wolosker et al., 1999) , and glycine, which is another endogenous coagonist for the NMDA receptor in the brain region, were slightly and transiently, but significantly increased contents. $, &, m, Indicate statistically significant differences in the time-point data at p<0.05, 0.01 or 0.001 as compared to the Ringer solution alone-infused controls : open symbols, n.s. # p<0.05, ## p<0.01, as compared to the animals treated with the intra-cortical infusion of (S)-AMPA in the presence of CTZ, NBQX or NASPM. The area under the curve (AUC) is also calculated by adding the areas under the graph of the concentration of the respective amino acid between each pair of every 20-min consecutive observation from 40 to 180 min of treatment (b, d, f, h) and expressed as a percentage of the respective control D-serine values (Table 1 ). * p<0.05, ** p<0.01 or *** p<0.001 as compared to the Ringer solution-infused controls ; # p<0.05, ## p<0.01 between the two groups linked by the solid line. The statistical significance of the data was evaluated using Dunnett's test for comparison among five groups in the concentrationrelated experiments (a, b), and using the two-tailed Student's t test (homogeneous variance) or Aspin-Welch's t test (heterogeneous variance) after adjustment of the p values for multiple tests using Bonferroni's method (c, d, e, f, g, h) . ; g) and the open bars display the period of (S)-AMPA (100 mM) infusion through the dialysis probe into the cortical portion. The concentrations of taurine in the cortical dialysates collected every 20 min were quantitatively determined using high-performance liquid chromatography with fluorometric detection. Each point represents the mean with S.E. mean of data obtained from 4-7 animals and expressed as a percentage of the respective basal taurine contents (Table 1) . $, &, and m, Indicate statistically significant differences in the time-point data at p<0.05, 0.01 or 0.001 as compared to the Ringer solution alone-infused controls : open symbols, n.s. # p<0.05 as compared to the animals treated with the intra-cortical infusion of (S)-AMPA in the presence of CTZ, NBQX or NASPM. The area under the curve (AUC) is also calculated by adding the areas under the graph of the concentration of the respective amino acid between each pair of every 20-min consecutive observation from 40 to following the intra-mPFC infusion of 100 mM (S)-AMPA in a NBQX-sensitive fashion (Fig. 4 a-d) when estimated both by the data at each time-point and by AUC. However, NASPM failed to affect the basal and increased levels of the extracellular L-serine and glycine (data not shown). The (S)-AMPA perfusion did not alter the L-glutamate (Fig. 4 e, f ) and L-glutamine ( Fig. 4 g, h) contents in the prefrontal dialysate.
Discussion
In the present study, by using an in vivo dialysis technique in freely moving rats, we first demonstrated that a locally applied AMPA type glutamate receptor selective agonist, (S)-AMPA, caused a concentration-related and an allosteric agonist-potentiating decrease in the extracellular contents of D-serine in the mPFC. This decrease is completely reversed by not only a competitive AMPA/ kainate receptor antagonist, NBQX, but also by a calcium permeable AMPA receptor antagonist, NASPM. The differential effects of (S)-AMPA on the contents of L-serine, glycine, L-glutamate, L-glutamine and taurine in the extracellular fluid observed in this study appear to deny the possibility that the alterations in the D-serine contents are due to a non-specific phenomenon.
As AMPA receptor overstimulation has been reported to cause cell death or various types of tissue damages (Dugan et al., 1995 ; Larm et al., 1997 ; John et al., 1999) , the (S)-AMPA-induced reduction in the extracellular D-serine contents could result from a complete or marked loss in the activities of the neural and/or glial cells around the site of the (S)-AMPA infusion. However, this is unlikely because : (1) an extreme attenuation of neural activity by tetrodotoxin failed to decrease the extracellular D-serine levels in the cortical area (Hashimoto et al., 1995) ; (2) in this study, there are no significant alterations in the extracellular L-glutamine concentrations (Fig. 4 g, h) whose decline is prominent when glial activity is inhibited by fluorocitrate (Largo et al., 1996 ; Kanematsu et al., 2006) ; (3) reversible changes in the extracellular taurine (Fig. 3) , glycine ( Fig. 4 ) and L-serine (Fig. 4) argues against the possibility that the (S)-AMPA infusion may produce an irreversible process of cell death ; (4) a remarkable increase in all of the prefrontal extracellular amino acids due to a leak from their large intracellular pools, which should be caused by the possible rupture of the cells surrounding the dialysis probe, was not observed in the (S)-AMPA-infused animals. In support of these discussions, a perfusion of (S)-AMPA up to 1 mM for 4 h (Larm et al., 1997) or up to 600 mM for 48 h (John et al., 1999) in primary cultures of mouse neocortical neurons, or AMPA up to 1 mM for 48 h in astrocyte cultures of mouse neocortex (Dugan et al., 1995) failed to trigger cell death.
The (S)-AMPA-induced, NBQX-reversible and CTZpotentiating nature of the reduction in the extracellular D-serine contents appears to support the idea that the AMPA receptor may participate in the inhibitory regulation of extracellular D-serine output in the prefrontal areas of the rat by the following data : (1) (S)-AMPA is a highly selective and potent agonist for the AMPA receptors (Watkins et al., 1990) ; (2) CTZ enhances the effects of an AMPA receptor agonist acting at the glutamate binding site by attenuating the agonist-provoked desensitization of the receptor through selectively binding to its allosteric agonist site (Partin et al., 1993 ; Yamada and Tang, 1993 ; Fucile et al., 2006 ; Krintel et al., 2012) ; (3) the NBQX disodium salt is shown to be an AMPA receptor-preferring non-NMDA glutamate receptor antagonist based on in vitro and in vivo observations that the antagonist is about 30-fold more potent in blocking the action of AMPA than that of kainate (Sheardown et al., 1990 ; Lodge et al., 1991) .
However, the inhibitory influence produced by the AMPA receptor stimulation is in conflict with previous results obtained from in vitro experiments that a bath application of AMPA agonists facilitates the release of preloaded [ 3 H]-D-serine or endogenous D-serine from cultured astrocytes (Schell et al., 1995 ; Mothet et al., 2005 ; Rosenberg et al., 2010) or neurons (Kartvelishvily et al., 2006 ; Rosenberg et al., 2010) in a primary culture, C6 glioma cells (Mothet et al., 2005) or retinal cells (Sullivan and Miller, 2010) . This discrepancy cannot be attributed to certain inappropriate conditions of this in vivo study because the (S)-AMPA-induced and NBQX-reversible increase in the prefrontal extracellular taurine contents in the present experiments is consistent with previous findings obtained by an in vivo dialysis method :
(1) AMPA produces a rapid, concentration-related, prominent and selective antagonist-reversible increase in the extracellular taurine contents in the primary motor cortex (La Bella and Piccoli, 2000) ; (2) the AMPA/kainate receptor antagonist, 6,7-dinitroquinoxaline-2,3-dione, significantly attenuated the elevations in the dialysate taurine levels produced by a selective glutamate uptake inhibitor, L-trans-pyrrolidine-2,4-dicarboxylic acid, in the prefrontal cortex (Del Arco et al., 1999) . AMPA receptormediated property of the modification of taurine levels is also grounded by the augmentation of the (S)-AMPAinduced increase in taurine contents by an AMPA 180 min of treatment (b, d, f, h) and expressed as a percentage of the respective control taurine values (Table 1 ). * p<0.05, ** p<0.01 or *** p<0.001 as compared to the Ringer solution-infused controls ; # p<0.05 between the two groups linked by the solid line ; n.s. The statistical significance of the data was evaluated using Dunnett's test for comparison among five groups in the concentration-related experiments (a, b) and using the two-tailed Student's t test (homogeneous variance) or Aspin-Welch's t test (heterogeneous variance) after adjustment of the p values for multiple tests using Bonferroni's method (c, d, e, f, g, h) . receptor potentiator, CTZ ( Fig. 3 c, d) . Although CTZ elicits multiple effects in the brain, such as blockade of the mGluR1 (Surin et al., 2007) , c-aminobutyric acid (GABA) A and GABA C receptors (Johnston et al., 2010) and simulation of epileptiform activity (Qi et al., 2006) , these effects cannot explain the simultaneous enhancement by CTZ of the (S)-AMPA-induced increase and decrease in taurine and D-serine levels, respectively, from the viewpoints of the following reports : (1) group I and III metabotropic glutamate receptor agonists increased (Oja and Saransaari, 2000) and GABA A and GABA C receptor blockade (unpublished data) did not affect extracellular taurine release ; (2) it is assumed that CTZ facilitates epileptiform activity by both enhancing glutamatergic neurotransmission and inhibiting GABAergic neurotransmission (Qi et al., 2006) ; (3) extra-AMPA receptor actions should only attenuate or enhance (namely, produce a unidirectional influence on) both of the aforementioned effects of (S)-AMPA on D-serine and taurine. Hence, the discrepant results between the present in vivo and the previous in vitro studies may reflect their distinct conditions in cellular interactions and neuronal circuits.
As for the in vivo responses of extracellular D-serine to the excitatory stimuli, in contrast to our study, some recent studies have reported that a fast (peaks at 10-15 min) and significant increase of extracellular D-serine contents is elicited by kainic acid or veratridine in the striatum (Ciriacks and Bowser, 2006 ; Rosenberg et al., 2010) . They performed in vivo dialysis experiments in anaesthetized animals and started to collect the brain perfusates for the quantitation of the extracellular contents of D-serine from the early post-operation stage (45 min). The exact variations in the responses of extracellular D-serine among the different conditions between their and our experiments, including the post-operation period to the start of sample collections, the use of anaesthesia, the dosage and duration of drug treatment and analysis time intervals, thus await further elucidation.
The attenuating influence of (S)-AMPA on extracellular D-serine levels is likely to be mediated by the calcium-permeable Glu2 A subunit-lacking AMPA receptor because NASPM, a selective antagonist for the AMPA receptor subtype (Tsubokawa et al., 1995) , completely reversed (S)-AMPA's influence. In contrast, NASPM failed to affect an (S)-AMPA-induced increase in the extracellular taurine levels. These results raise the possibility that the calcium-permeable and -impermeable AMPA receptor might differentially regulate the signals of brain D-serine and taurine. The observation that the calcium-permeable AMPA receptor mediates synaptic depression induced by a very low frequency test pulse stimulation at the naive primary visual cortex of the preweaning rat (Meng et al., 2010) suggests that such a down-regulation of synaptic activity could be involved in the inhibitory influence by the AMPA receptor subtype on the extracellular D-serine release in the brain. Control AMPA (100 µM) Fig. 4 . Effects of local perfusion of (S)-AMPA [an active enantiomer at the a-amino-3-hydroxy-5-methyl-4-isoxazolepropioinic acid (AMPA) receptor] alone or in combination with 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]-quinoxaline-7-sulfonamide disodium salt (NBQX) into the medial prefrontal cortex on the extracellular contents of various amino acids in the cortical region of the rat. The solid black symbols indicate the continuous local application of Ringer solution containing NBQX (100 mM ; a, c) and open symbols display the period of (S)-AMPA (100 mM) infusion (a, c, e, g) through the dialysis probe into the medial prefrontal cortex of the freely moving rats. The concentrations of L-serine, glycine, L-glutamate and L-glutamine in the cortical dialysates collected every 20 min were quantitatively determined using high-performance liquid chromatography with fluorometric detection. Each point represents the mean with S.E. mean of data obtained from 4-8 animals and expressed as a percentage of the basal L-serine, glycine, L-glutamate and L-glutamine contents (Table 1) . $, Indicates statistically significant differences in the time-point data at p<0.05, 0.01 or 0.001 as compared to the Ringer solution alone-infused controls : open symbols, n.s. # p<0.05, ## p<0.01, ### p<0.001 compared to the animals treated with the intra-cortical infusion of (S)-AMPA in the presence of NBQX. The area under the curve (AUC) is also calculated by adding the areas under the graph of the concentrations of L-serine and glycine between each pair of every 20-min consecutive observation from 40 to 180 min of treatment (b, d, f, h) and expressed as a percentage of the respective control L-serine, glycine, L-glutamate and L-glutamine values (Table 1) . ** p<0.01 as compared to the Ringer solution-infused controls ; # p<0.05, ### p<0.001 between the two groups linked by the solid line ; n.s. The statistical significance of the data was evaluated by two-tailed Student's t test (homogeneous variance) or Aspin-Welch's t test (heterogeneous variance) for comparison between the two groups and by that for comparison among more than three groups after adjustment of the p values for multiple tests using Bonferroni's method.
